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Abstract:  Objective:  To  determine  the  population-based  epidemiology  of  fetal  alcohol 
syndrome  (FAS)  and  other  fetal  alcohol  spectrum  disorders  (FASD)  in  towns 
representative of the general population of central Italy. Methods: Slightly revised U.S. 
Institute of Medicine diagnostic methods were used among children in randomly-selected 
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schools  near  Rome.  Consented  first  grade  children  (n  =  976)  were  screened  in  Tier  I  
for  height,  weight,  or  head  circumference  and  all  children  <10th  centile  on  one  of  
these  measurements  were  included  in  the  study.  Also,  teachers  referred  children  for 
learning or behavioral problems. Children meeting either of these two criteria, along with 
randomly-selected  controls,  advanced  to  Tier  II  which  began  with  a  dysmorphology 
examination.  Children  with  a  possible  FASD,  and  controls,  advanced  to  Tier  III  for 
neurobehavioral  testing,  and  their  mothers  were  interviewed  for  maternal  risks.  Final 
diagnoses  using  indicators  of  dysmorphology,  neurobehavior,  and  maternal  risk  were  
made  in  formally-structured,  interdisciplinary  case  conferences.  Results:  Case  control 
comparisons of physical, neurobehavioral, and maternal risk variables are presented for  
46 children with an FASD and 116 randomly-selected controls without a diagnosis on the 
FASD continuum. Rates of diagnoses within the FASD continuum are then estimated from 
these in-school data via three different methods. The range of rates of FAS produced by 
these methods is between 4.0 to 12.0 per 1,000; Partial FAS ranges from 18.1 to 46.3  
per 1,000; and an FASD was found in 2.3% to 6.3% of the children. Conclusions: These 
rates are substantially higher than previous estimates of FAS and overall FASD for the 
general populations of Western Europe and the U. S., and raise questions as to the total 
impact of FASD on mental deficit in mainstream populations of Western Europe and the 
United States where the majority are middle class and are not believed to be characterized 
by heavy episodic drinking. 
Keywords:  fetal  alcohol  spectrum  disorders  (FASD);  fetal  alcohol  syndrome  (FAS); 
epidemiology; prevalence; Italy; alcohol consumption 
 
1. Introduction  
Moderate  daily  or  frequent  drinking  is  believed  to  be  the  predominant  pattern  of  alcohol 
consumption  among  a  majority  of  females  in  Italy.  While  individual  cases  of  children  with  fetal 
alcohol syndrome (FAS) in Italy exist in the published literature [1-5], studies in Italy have frequently 
shown no relationship between maternal alcohol consumption and reduced birth weight or pregnancy 
loss [6-9]. But at least one article from Italy has linked prenatal alcohol use and smoking with low 
birth weight [10].
 Another reported that over one-third of women delivering in Italian hospitals were 
daily  drinkers,  and  that  drinking  continued  after  recognition  of  pregnancy  [11].  Overall,  maternal 
drinking in this later study [11] was not associated with lower birth weight. But birth weight was 
affected by ―abusive‖ drinking, and alcohol abuse and binge drinking were cited as rare among women. 
Primatesta et al. [9] also reported low rates of pre-pregnancy binge drinking (1.4%) among women in 
Milan; however, their data indicate that 9% of women reported risky to very risky average weekly 
alcohol consumption, with 29% drinking daily during pregnancy, rates substantially higher than those 
reported in the United States (U.S.).  
The majority of all studies of the prevalence of fetal alcohol spectrum disorders (FASD) are from 
the  U.S.,  and  most  have  utilized  clinic  [12,13]  or  record-based  systems  [14-16]  without  active Int. J. Environ. Res. Public Health 2011, 8                 
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recruitment. Such methods under-report prevalence and describe only the most severe cases [17,18]. 
Without active case ascertainment, many children with FAS and FASD are neither detected [16,19-21] 
nor referred for diagnosis [20,22-25]. Therefore, many cases of FASD, from FAS to alcohol-related 
neurodevelopmental disorder (ARND), have not been well-defined in the literature because of this 
selectivity in the referral process and the lack of active outreach [18]. 
In population-based, active case ascertainment studies, FASD cases are sought through structured 
outreach in a defined population [20]. All published, active case ascertainment studies in the U.S. 
except  one [21],  were  carried  out  in  predominantly  minority  and  low  socioeconomic  status  (SES) 
communities all of these utilized an active outreach system to refer children to specialty clinics [26-31].
 
Three prevalence studies utilizing in school studies of mostly low-SES populations have been reported 
from South Africa [32-37], studies which have been seminal in defining the value and techniques  
for in-school research methodology for FASD. This paper utilized in-school methods pioneered in 
South Africa.  
A first wave of research in this area of Italy [38-40], revealed many alcohol-linked disabilities and a 
FAS prevalence of 3.7 to 7.4 per 1,000. Overall FASD was estimated as 35 per 1,000 (3.5%) [38], 
much higher than existing estimates for mainstream populations in a western country. As originally 
planned and funded, two samples (waves) of data were collected in the same region in order to sample 
more completely for FASD in this population. Complete data from both waves of this study in Italy are 
presented here to more fully address these questions: are FAS and other forms of FASD common in 
Italy; what are the characteristics of Italian children with FAS, or other diagnoses within FASD; and 
by implication, is the prevalence of FASD higher in the western world than estimated previously? 
2. Methods 
2.1. Institute of Medicine (IOM) Diagnostic Categories of FASD 
The diagnostic components and criteria for FASD of the U.S. Institute of Medicine [20], recently 
revised  slightly  by  the  authors  of  this  study  [41],
 were  used  for  classification  of  study  children:  
(1) facial and other dysmorphology, (2) diminished physical growth, (3) intellectual, developmental, 
social,  and  neuropsychological  assessments,  and  (4)  maternal  alcohol  consumption,  physical,  and 
social risk factors. Also, known anomalies of genetic and other teratogenic origins are ruled out by 
clinicians (dysmorphologics/medical geneticists) before an FASD diagnosis is made. Data for each of 
the above components were collected and analyzed independently within each of the above domains. 
A  formal,  data-driven  case  conference  was  held  for  final  diagnosis  where  the  professionals 
representing each domain present the results obtained for each child. Thus, the diagnosis is made by 
the multidisciplinary team. 
The  diagnoses  in  the  IOM  system  are:  FAS,  Partial  FAS,  alcohol-related  neurodevelopmental 
disorder (ARND), alcohol-related birth defects (ARBD), or not FAS [20,41]. For FAS a child must 
have: (1) a characteristic pattern of minor facial anomalies including at least 2 or more of the key facial 
features  of  FAS  (palpebral  fissures  ≤  10th  centile,  thin  vermilion  border,  or  smooth  philtrum),  
(2)  evidence  of  prenatal  and/or  postnatal  growth  retardation  (height  or  weight  ≤  10th  centile),  
(3) evidence of deficient brain growth (structural brain anomalies or occiptofrontal head circumference Int. J. Environ. Res. Public Health 2011, 8                 
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(OFC) ≤ 10th centile), and if possible, (4) confirmation of maternal alcohol consumption from the 
mother or a knowledgeable collateral source [41]. 
For  Partial  FAS  (PFAS),  a  child  must  have:  (1)  evidence  of  a  characteristic  pattern  of  facial 
anomalies including two or more of the three key features of FAS (above), (2) one or more other 
characteristics such as prenatal or postnatal growth retardation (≤10th centile in height or weight), 
hypoplastic midface, occilar defects, abnormalities of the fingers, or other physical defects linked to 
prenatal alcohol exposure in humans, (3) small OFC (≤10th centile), and/or evidence of a complex 
pattern  of  behavioral  or  cognitive  abnormalities  inconsistent  with  developmental  level  and 
unexplainable  by  genetic  composition,  family  background,  or  environment  alone;  and  if  possible,  
(4) direct or collateral confirmation of maternal alcohol consumption [41].
  
For a diagnosis of ARND a child must have documentation of significant prenatal alcohol exposure, 
display neurological or structural brain abnormalities (e.g., microcephaly), or manifest evidence of a 
complex  and  characteristic  pattern  of  behavioral  or  cognitive  abnormalities  inconsistent  with 
developmental level as measured by test batteries such as those in Table 2 and not explained by 
genetic predisposition, family background, or environment alone [41]. 
For
 ARBD, a child must have
 confirmed prenatal alcohol exposure, evidence of the characteristic 
pattern of facial anomalies, including two or more of the following: short palprebral fissures, thin 
vermillion border, and/or smooth philtrum, as well as either major malformations of a pattern or minor 
malformations, but generally rather normal neurobehavioral performance [41]. 
Diagnosis of FAS or PFAS without a confirmed history of alcohol exposure must be viewed as 
tentative, but original IOM criteria allow for an FAS diagnosis without direct (maternal) reports of 
exposure [20], and our revised criteria [41], permit it in a diagnosis of PFAS if all other signs point 
consistently to a regular pattern of drinking at other times (e.g., prior to being told of pregnancy,  
and 3 months prior to pregnancy). Collateral reports are valuable sources of information which were 
utilized, but could not be obtained for all mothers not interviewed. Many women in well-educated, 
developed populations do not admit to drinking during pregnancy [42]. 
2.2. Overall Study Design and Sampling 
First grade students were studied from two health districts of the Lazio region outside of Rome, an 
area  of  small  towns,  some  suburban,  and  other  relatively  self-sufficient,  rural  areas.  These  health 
districts are considered relatively representative of central Italy. 
The study is a cross-sectional, observational, case-control design with retrospective collection of 
maternal risk information. Twenty-five schools were randomly selected in wave I (2005–2006), from 
the  68  elementary  schools  in  two  health  districts,  and  25  were  selected  in  wave  II  (2006–2007). 
Random sampling with replacement resulted in double selection of seven schools who participated in 
both  years;  thus,  43  different  schools  participated.  Italian  team  members  approached  school 
administrators to explain the study, gain entry, and contact parents/guardians of all first grade children 
via normal school communication channels. Total enrollment in the first grade of selected schools was 
1,087 and 902 in waves I and II. Positive consent forms were returned by 49% of the parents with only 
one mail out. Subsequent distributions of consent forms will generally yield a higher percentage of Int. J. Environ. Res. Public Health 2011, 8                 
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participation, but this study was severely limited by time and monetary resources, so one mailout was 
all that was possible.  
Figure 1. Methodology of the Lazio Region (Italy) FASD study with Sampling Procedures  
and Numbers. 
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The total sample was 976 children; 11 of the initially consented children were withdrawn by their 
parents at some later point in the study or they moved from the study schools. All procedures were 
approved by the Ethics Committee of the Italian health district (ASL RMG) and the University of New 
Mexico Health Sciences IRB (approval #03 089). 
The randomly-selected control children were chosen by random number tables from all consented 
children  to  provide  a  representative  population  of  normal,  not-FASD  children.  True  to  the  
population-based nature of this study they represent children of all sizes and attributes, including both 
those children who are exposed and unexposed to alcohol during pregnancy. Nevertheless, no control 
children have an FASD or any other major defect or anomaly. In any given population, especially in 
certain European populations where some drinking among women is practiced almost universally, 
there are many completely normal children who are exposed to some alcohol in the prenatal period, yet 
they do not suffer any detectable anomalies or deficits from the exposure. So the controls in this and our 
other population-based studies are representative of the normally-functioning children in these schools. 
Because the first tier screening in this in-school study primarily sought children who were small or 
had small OFC, we were most likely to detect children with a severe form of FASD, e.g., FAS and 
PFAS. That was our intent. Other than the children who were specially referred by teachers as having 
learning  or  behavioral  problems,  we  undoubtedly  missed  cases  of  ARND.  Monetary  and  time 
limitations dictated that we limit our first tier screening to a small number (≤10th centile on OFC 
and/or height and weight) in order to locate the most affected. Teacher referrals were encouraged by 
the research team and were made for children whom the teachers believed were struggling with their 
lessons, were behaviorally disordered, or showed some other signs of having features of FASD.  
2.3. The Two-Tiered System of Entry and Diagnosis Employed in the Study 
Data on growth, development, and dysmorphology were collected by a two-tiered method, and US 
National Center for Health Statistics growth charts were used to determine the centiles for each child. 
In Tier I, consented children were screened for height, weight, and head circumference (OFC) in their 
schools. If a child’s measurements were ≤10th centile on OFC and/or height and weight, he/she was 
referred  for  Tier  II  screening,  which  began  with  the  dysmorphology  exam  in  each  school  by 
dysmorphologists and research staff. Also, teachers were asked for and provided referrals of children 
with learning problems who were included in Tier II if consented. Six dysmorphologists worked with 
checklists  to  assess  growth  and  morphology  [41];  each  child  was  examined  by  two  physicians 
independently, scribes recorded data, and all were blinded from information from all other sources. 
Findings of the two examiners were later compared for each child during daily debriefing sessions 
where a preliminary diagnosis was assigned: probable FAS, deferred-suspected FASD, or not FAS. 
Children  with  a  preliminary  diagnosis  of  any  possible  FASD  (n  =  118)  were  advanced  to 
neurobehavioral testing (See Figure 1). 
2.4. Developmental (IQ, Cognitive and Behavioral) Testing for FASD Suspects and Controls 
Randomly-selected control children (n = 116) from the same classrooms were provided identical 
physical  exams  and  neurobehavioral  testing  as  provided  to  the  suspects  by  local  professionals. 
Neurobehavioral testing was carried out by licensed Italian psychologists and the testing included: Int. J. Environ. Res. Public Health 2011, 8                 
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Rustioni Qualitative Test [43], Raven’s Colored Progressive Matrices [44], the Italian translation of 
the Wechsler Intelligence Scale for Children–Revised (WISC-R) [45] the Personal Behavior Checklist 
(PBCL) [46], the Pelham Disruptive Behaviors Disorder (DBD) Scale (filled out by both parents and 
teachers)  [47],  and  the  Questionario  Osservativo  per  I’Identificazione  Precoce  delle  Difficultà   di 
Aprendimento (IPDA) [48]. 
The Rustioni Qualitative Test is a measure of Italian language linguistic understanding. It was 
developed and normed on the Italian population. The IPDA is an Italian normed test designed to 
identify  difficulties  in  learning  by  measuring  academic  achievement.  The  Raven  CPM  is  a 
standardized test that assesses nonverbal reasoning ability. The PBCL is a short, easy to administer 
scale that purports to measure the behavioral characteristics of FAS, regardless of age, race, sex or IQ. 
The DBD Rating scale provided measures of inattention and hyperactivity/impulsivity. 
2.5. Maternal Interviews for Mothers of FASD Suspects and Controls 
Thirty-nine of 46 mothers of the children with final diagnoses of an FASD (85%) were interviewed 
on maternal risk factors exploring their lives before, during, and after the index pregnancy including: 
childbearing, drinking, drug use, marital status, SES, demographics, religiosity, and nutrition. The 107 
(92%) consenting mothers of the control children became the maternal comparison group.  
2.6. Statistical Analysis 
Data were processed via EPI Info software [49] and SPSS. In Tables 1 and 2 one-way Analysis of 
Variance is used to compare children with severe FASD and controls. Dunnett’s C tests were used for 
post-hoc  analyses.  Table  3  employs  t-tests  and  chi-square  to  compare  mothers  of  FASD  subjects 
combined with control mothers. Zero order correlations (Pearson r) of selected variables are reported 
in the text after Table 3. In Table 4, FASD prevalence estimates are presented using two denominators, 
high (sample as the denominator) and low (total enrolled children), as specified in the table footnotes. 
Finally, alternative estimates of FASD are presented in the text using the conversion rates of controls 
to an FASD diagnosis. 
3. Results  
3.1. Demographic and Child Physical Traits 
Table 1 compares demographic and physical traits of study children. Because the focus of this study 
was on the most severe forms of FASD, one child with ARND and one with ARBD were omitted in 
Tables 1 and 2. But they are included in Table 4 for the total prevalence of FASD. There is no 
difference in the groups by age and sex, reinforcing the strength of in-school studies utilizing randomly 
selected  controls  for  these  variables.  Also,  the  values  for  the  control  group  are  similar  to  those 
collected for the whole sample, indicating that random methods produced a representative sample. 
Specifically, children with FAS have the most significantly deficient measures of height, weight, BMI, 
head circumference, short intercanthal distance, hypoplastic midface, strabismus, narrow vermillion 
border, maxillary arc, mandibular arc, and heart murmur, while the controls have the best measures as 
expected from both the study design and criteria for FASD. The spectrum effect is evident, with FAS Int. J. Environ. Res. Public Health 2011, 8                 
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children having the most anomalies and worst growth and development, the features of the children 
with PFAS are less severe, and controls are relatively unaffected. But slight exceptions to the spectrum 
effect exist with some significant variables: palpebral fissure length (FAS and PFAS are equally small), 
philtral length (PFAS and FAS equally long), ptosis (PFAS have the only feature here) and smooth 
philtrum (FAS and PFAS have equally high percentages).  
Table 1. Demographic and growth parameters for all study children, children with a final 
diagnosis of FAS, partial FAS, and randomly selected controls: Lazio Region, Italy. 
Variable 
Children 
In Study 
(n = 970) 
Children 
With FAS 
(n = 8)**** 
Children 
With PFAS 
(n = 36) 
Control 
Children 
(n = 116) 
P
 
Sex (%) 
 Males 
 Females 
 
50.6 
49.4 
 
37.5 
62.5 
 
52.8 
47.2 
 
52.6 
47.4 
 
 
NS (0.706)
a  
Age (months) 
 Mean (SD) 
 
79.5 (4.2) 
 
80.9 (2.9) 
 
79.4 (4.3) 
 
79.5 (3.5) 
 
NS (0.577)
b 
Height (cm)* 
 Mean (SD) 
 
121.5 (5.5) 
 
113.6 (3.6) 
 
118.0 (5.0) 
 
121.5 (4.9)** 
 
<0.001
b 
Weight (kg)* 
 Mean (SD) 
 
25.1 (5.2) 
 
18.8 (3.1) 
 
22.2 (3.7) 
 
25.1 (4.2)** 
 
<0.001
b 
Children’s BMI* 
 Mean (SD) 
 
16.8 (2.8) 
 
14.6 (2.9) 
 
15.9 (1.76) 
 
16.9 (2.3) 
 
0.002
b 
BMI Percentile* 
 Mean (SD) 
 
60.9 (31.2) 
 
20.6 (32.6) 
 
51.4 (29.0) 
 
65.6 (29.4) 
 
<0.001
b 
Occipital Circumference (OFC) (cm)* 
 Mean (SD) 
 
51.9 (1.5) 
 
49.1 (1.0) 
 
50.6 (1.7) 
 
52.0 (1.3)** 
 
<0.001
b 
Palpebral Fissure Length (PFL) (cm) 
 Mean (SD) 
 
 
 
2.4 (0.1) 
 
2.4 (0.1) 
 
2.5 (0.1) 
 
<0.001
b 
Short Innercanthal Distance (ICD) 
(≤25%) 
  25.0  19.4  6.0  0.022 
Percent PFL is of ICD 
 Mean(SD) 
   
84.0 (10.4) 
 
87.9 (9.9) 
 
89.4 (7.2) 
 
NS (0.139)
b 
Philtrum Length (cm) 
 Mean 
   
1.5 (0.2) 
 
1.5 (0.2) 
 
1.4 (0.2) 
 
0.035 
Hypoplastic Midface (%)    62.5  30.6  12.9  0.001
 a  
Maxillary Arc (cm) 
 Mean 
   
23.3 (0.5) 
 
24.4 (1.1) 
 
24.9 (0.9) 
 
<0.001 
Mandibular Arc (cm) 
 Mean (SD) 
   
23.9 (0.5) 
 
24.9 (1.2) 
 
25.6 (1.0) 
 
<0.001 
Strabismus (%)    12.5  5.6  1.7  0.0034
a  
Ptosis (%)    0.0  8.3  0.0  0.005
a 
Smooth Philtrum (%)    87.5  91.7  13.8  <0.001
a  
Narrow Vermillion Border (%)    100.0  94.4  21.6  <0.001
a  
Heart Murmur (%)    12.5  0.0  1.7  NS (0.060)
a  
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Table 1. Cont. 
Clinodactyly (%)    50.0  55.6  36.2  NS (0.105)
a  
Camptodactyly (%)    0.0  13.9  4.3  NS (0.088)
a 
Dysmorphology Score*** 
Mean (SD) 
   
15.8 (1.9) 
 
11.2 (4.0) 
 
3.6 (2.9) 
 
<0.001
b 
NS = Not Significant. a. χ
2 test of data comparing children with FAS, PFAS, and controls; a Fisher’s 
exact test when there are cells with an expected value of less than five. b. ANOVA of data comparing 
children with FAS, PFAS, and controls. * Measurements are actual values at the time of screening and 
exams. Percentiles were calculated via standardized NCHS growth charts for age and sex and used  
(1) when considering inclusion of children in the study, (2) for comparison, and (3) when diagnosis was 
made. ** Measurements at time of Tier I screen, therefore they are directly comparable to all other 
groups. ***The dysmorphology score is a weighted measure of dysmorphic features. It is not utilized in 
diagnostic  assessment,  but  provides  a  quantitative  measure  of  dysmorphic  features  for  comparison 
purposes [41]. **** There was one set of twins among the FASD cases. 
 
Nevertheless, with each of these later variables, F-values of difference were significant between the 
three groups and measures for the FAS, and as predicted by the literature PFAS children are worse 
than controls [20,41]. Total dysmorphology scores (overall severity of deformities and lack of physical 
development) clearly form the expected spectrum (FAS = 15.8, PFAS = 11.2, and 3.6 for controls). 
 
3.2. Neurodevelopmental Traits of Children 
Scores on neurodevelopmental tests (Table 2) indicate average scores, non-verbal I.Q. (Raven) and 
verbal, comprehension (Rustioni), and academic understanding (IPDA) are significantly lower for FAS 
children than PFAS and controls. While there are no post-hoc significant differences between FAS and 
PFAS  IQ  on  these  measures,  a  significant  difference  exists  between  the  PFAS  and  controls.  The 
WISC-R non-verbal IQ scale scores form a significant spectrum with FAS children scoring the lowest 
(85.5), PFAS next (95.4), and controls the highest (113.7). The Pelham Disruptive Behaviors Disorder 
(DBD) data in Table 2 are the parent ratings from these children. Parents rated the FASD children as 
less attentive than controls, and post-hoc analyses show the PFAS children to be significantly less 
attentive than controls. Overall, hyperactivity was greatest among the PFAS group and lowest among 
the FAS group, the latter being an unusual finding in the literature. Post-hoc analyses of hyperactivity 
were not significantly different between groups and are not presented in Table 2. Italian parents seem 
less likely than American parents to rate children as hyperactive. PFAS children also registered the 
greatest number of behavioral problems on the PBCL, and the FAS and control children have identical 
scores.  Finally,  classroom  academic  achievement  (IDPA)  is  lowest  for  FAS  children,  with  PFAS 
children intermediate; controls are doing the best. 
 
 Int. J. Environ. Res. Public Health 2011, 8                 
 
2340 
Table 2. Demographic and behavioral indicators of controls and children with a FASD 
diagnosis and comparisons of maternal age and drinking measures across groups: Lazio 
Region, Italy. 
  Final Diagnosis FASD   
 
 
 
FAS 
Mean  
Score (SD) 
 
Partial FAS 
Mean  
Score (SD) 
 
Controls 
Mean 
Score (SD) 
 
 
Test  
Statistic *** 
 
 
 
df 
 
 
 
probability 
Child Variables  (n = 8)  (n = 36)  (n = 113)       
Total dysmorphology score  15.75
bc (1.90)  11.22
ac (3.95)  3.60
ab (2.90)  F = 122.76  2/160  <0.001 
Raven percentile  50.62 (28.71)  55.55
c (22.28)  70.97
b (21.20)  F = 8.99  2/157  <0.001 
Rustioni errors  8.00 (3.91)  7.76
c (1.88)  5.27
b (2.51)  F = 8.37  2/85  <0.001 
Rustioni qualitative  3.13 (2.03)  3.56
c (2.09)  4.78
b (1.74)  F = 8.00  2/156  <0.001 
Inattention DBD  5.12 (7.01)  7.28
c (8.10)  2.21
b (3.72)  F = 12.97  2/154  <0.001 
Hyperactivity DBD****  1.75 (2.71)  4.86 (6.71)  2.19 (4.26)  F = 4.23  2/156  0.016  
WISC-R Non-verbal IQ****  85.50 (22.21)  95.42 (15.45)  113.69 (17.48)  F = 11.03  2/71  <0.001 
PBCL****  4.80 (5.76)  7.37 (6.84)  4.80 (5.76)  F = 6.20  2/136   0.003 
IDPA total score  15.50 (4.98)  17.03 (4.64)  21.11 (5.78)  F = 9.68  2/151  0.001 
Maternal Variables  (n = 8)  (n = 34)  (n = 112)       
Maternal age during index 
pregnancy  
Mean (SD) 
 
 
31.50 (6.00) 
 
 
30.48 (5.20) 
 
 
29.25 (5.38) 
 
 
F = 1.11 
 
 
2/145 
 
 
NS(0.331) 
Report drinking during 
pregnancy (%) 
 
 
50.0 
 
54.8  40.0  
2 = 2.28  2/144  NS(0.320) 
Mean number of drinks 
current week** (SD) 
 
10.37 (18.92) 
 
1.78 (4.02) 
 
1.52 (2.80) 
 
F = 10.94 
 
2/145 
 
<0.001 
Mean drinks per current 
drinking day** (SD) 
 
1.56 (2.69) 
 
.63 (.53) 
 
.61 (.52) 
 
F = 5.39 
 
2/145 
 
0.006 
* = all scores standardized for age of child at time of testing. ** = Among those who reported drinking 
during pregnancy; includes current non-drinkers. *** = Univariate Analysis of Variance (ANOVA) or 
chi-square.  ****  =  Ratings  performed  by  parents.  Post-hoc  analysis,  significantly  different  from:  
FAS = a, PFAS = b, Controls = c: Dunnett’s C adjustment, the mean difference is significant at the  
0.05 level. NS = not statistically significant. 
3.3. Maternal Traits 
Not all mothers of FASD children reported drinking during the index pregnancy (Table 2), but 
mothers of the FASD children reported significantly more drinks per week and per day at interview 
(―current  drinking‖).  Notably,  mothers  of  FAS  children  reported  the  greatest  quantities  of  current 
drinking,  as  current  drinking  variables  preceded  questions  of  prenatal  drinking.  Like  many  other 
studies of FASD, mothers of the FAS and PFAS children were older, but the difference was not 
significant in this relatively small sample. 
Table 3 indicates that virtually all mothers are current drinkers (93 to 97%). Mothers of children 
with FASD report heavy current drinking and drinking during the 2
nd and 3
rd trimesters of the index 
pregnancy.  Lack  of  candor  among  a  substantial  number  of  the  mothers  of  affected  children  was Int. J. Environ. Res. Public Health 2011, 8                 
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reported by the interviewers. No smoking variables were significantly different between groups. Some 
other significant variables include: mothers of FASD children were lower in educational attainment, 
higher in religiosity, and had lower status employment. No other differences were significant, but most 
were in a direction predicted in the literature. 
Table  3.  Demographic,  socioeconomic,  and  maternity  variables  and  substance  use 
measures by mothers of the children with FASD and randomly selected controls: Lazio 
Region, Italy. 
Variable 
Mothers of 
children 
with FASD 
(n = 39) 
Control 
mothers 
(n = 107) 
Test  
statistic P 
OR  
(95% CI)
d 
Demographic and Socioeconomic Variables     
   
Mean Age (yrs) on day of interview (SD)  37.2 (5.3)  36.1 (5.4)  NS (0.260)
b   
Educational attainment (%) 
Elementary 
Junior high 
Senior high 
Beyond Senior High 
College Degree 
 
7.7 
46.2 
23.1 
5.1 
17.9 
 
1.9 
27.1 
51.4 
1.9 
17.8 
 
 
 
 
 
0.015
 a,e 
 
Religiosity Index - Mean (SD)  4.8 (2.1)  3.9 (2.2)  0.025
b   
Among those employed, actual job (%) 
Manual worker 
Office worker 
Manager in an office 
Manager 
Other 
 
50.0 
44.4 
0.0 
5.6 
0.0 
 
23.5 
54.4 
1.5 
19.1 
1.5 
 
 
 
 
 
NS (0.212)
a,e 
 
Substance Use Variables  (n = 30)  (n = 78)     
Current drinker
1 (of ever drinkers) - %  93.3  97.4  NS (0.311)  0.37 (0.03–3.95) 
Mean number of drinks last month
2  
(current drinkers) (SD) 
20.3 (46.4)  8.7 (12.0)  0.045
b   
Among ever drinkers, drinking during: 
1
st trimester of pregnancy with index child - % 
 
53.3 
 
36.7 
 
NS (0.115)
a  
 
1.97 (0.77–5.08) 
2
nd trimester of pregnancy with index child - %  
3
rd trimester of pregnancy with index child - %  
60.0 
56.7 
34.2 
34.2 
0.014
a  
0.033
a 
2.89 (1.11–7.60) 
2.52 (0.97–6.56) 
Current smoker (of those who ever smoked) - %  34.8  57.7  NS (0.067)
a   0.39 (0.12–1.22) 
Percent smoked 3 months before index pregnancy 
(among ever smokers)  
73.9  71.2  NS (0.806)
a  1.15 (0.33–4.07)  
Percent who smoked during index pregnancy(ever 
smokers)  
31.8 
 
28.8 
 
NS (0.798)
a   1.15 (0.34–3.87) 
1. Consumed alcohol in 12 months preceding interview. 2. Includes those who did not drink in past month.  
NS = not statistically significant. a. X
2 test. b. t-test. c. Difference of proportions test. d. 95% confidence 
intervals calculated via the Cornfield technique. e. Calculations of chi-square-based odds ratio not possible 
for this variable as it is not a 2 ×  2 configuration. Int. J. Environ. Res. Public Health 2011, 8                 
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3.4. Correlation Analyses 
There were some important significant zero-order correlations produced in this study which link 
mother’s current drinking and their children’s inattention scores on the DBD scale (r = 0.19; F = 5.03; 
2/143; p < 0.05) and dysmorphology score (r = 0.19; F = 5.67; 2/142; p < 0.05). Similar significant 
correlations linked maternal weight and the child’s non-verbal I.Q.; the higher the mother’s weight the 
higher the child’s I.Q. (r = 0.16; F = 3.92; 2/143; p < 0.05). For the children: head circumference  
(r = 0.27; F = 12.72; 2/142; p < 0.001), smooth philtrum (r = −0.28; F = 18.56; 2/142; p < 0.001), 
narrow vermilion (r = −0.21; F = 7.09; 2/143; p < 0.01), ptosis (r = −0.16; F = 3.90; 2/141; p < 0.05) 
and total dysmorphology score (r = −0.23; F = 9.14; 2/143; p < 0.01) are all significantly correlated 
with the child’s non-verbal I.Q. 
3.5. Final Diagnosis Summary 
FAS 
In this Italian sample, 50% of the children diagnosed with FAS in the final case conference had all 
three ―cardinal‖ or key facial features of FAS (short PFL, smooth philtrum, and narrow vermilion 
border). The other 50% had two of these facial features, often along with other facial dysmorphia  
(e.g., wide intercanthal distance). Furthermore, all children (100%) diagnosed with FAS met criteria 
for growth retardation and OFC at <10th centile. For the drinking data, 100% of the mothers of FAS 
children were determined to be drinkers through collateral reports or self-report. All of the mothers of 
FAS children who reported drinking (63%) in their lifetime reported drinking at 3 months prior to 
pregnancy, and of those who reported drinking during the index pregnancy, (after they found out they 
were pregnant), 50% reported drinking in all three trimesters and 25% in two trimesters and 25% in 
one.  In  the  final  diagnoses  the  five  children  born  to  mothers  who  reported  drinking  in  the index 
pregnancy are reported as ―confirmed alcohol exposure,‖ and the other three are reported in Table 4 as 
―without direct confirmation of alcohol use during pregnancy.‖ 
PFAS 
For this sample 33% of the children with PFAS had all three key facial features and 67% had two. 
Most PFAS children had other features of facial dysmorphia, e.g., hypoplastic midface, ptosis, or 
palpebral fissures (PFL) that were small (low %) compared to the innercanthal distance (ICD). Their 
overall dysmorphology scores were also high (11.2 ±  SD of 4.0) for PFAS cases indicating other minor 
anomalies associated with prenatal alcohol exposure and FASD (Table 1). All of the PFAS cases 
diagnosed had scores on the intelligence, cognitive, and behavioral measures which were significantly 
deficient or problematic (Table 2). All but seven of the mothers of PFAS children were interviewed 
and  of  those  who  reported  drinking  at  any  time  in  their  lives,  87%  reported  drinking  during  the  
3 months prior to the index pregnancy; 58% of all mothers specifically reported drinking after their 
pregnancy was confirmed. Seventy-five percent of the mothers who reported drinking by trimester 
confirmed drinking in all three trimesters, the other 25% in only 1 or 2 trimesters. If a mother of a 
child with PFAS did not directly report drinking during the index pregnancy, then the case is listed in Int. J. Environ. Res. Public Health 2011, 8                 
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Table 4 as ―diagnosis without direct confirmation of alcohol use during pregnancy,‖ even though in 
some cases collateral reports may have indicated alcohol use during pregnancy. 
The one child diagnosed with ARND had minimal dysmorphology consistent with FAS or PFAS, 
yet  his  mother  reported  heavy  drinking  and  his  pattern  of  cognitive  and  behavioral  traits  was 
significantly deficient from normal, and consistent in pattern or profile with the children with FAS or 
PFAS. The child diagnosed with ARBD has substantial dysmorphology, but relatively average I.Q. 
and behavioral performance.  
3.6. Prevalence Findings 
In Table 4 the prevalence findings and the estimates for the range of FASD diagnoses are presented 
utilizing  several  techniques.  First,  the  sample  rates  are  calculated  using  the  denominator  of  total 
consented children (n = 976). These are presented in column ―a‖. The rate of FAS is 8.2 per 1,000 
children, the rate PFAS is four times higher than FAS at 36.9 per 1.000 and the overall rate of FASD is 
47.1 per 1,000 using these sample data. Furthermore, in column ―b‖, 95% confidence intervals (CI) 
were calculated from the two cohort samples yielding a range in the sample rates of: 6.5 to 10.1  
per 1,000 for FAS, 32.7 to 40.6 per 1,000 for PFAS, and 33.4 to 62.6 per 1,000 for total FASD. 
Table 4. Cases diagnosed and estimated rates of FASD among first grade school children 
in the Lazio Region, Italy. 
  Diagnosis with 
direct 
confirmation 
of alcohol use 
during 
pregnancy 
Diagnosis w/o 
direct 
confirmation 
of alcohol use 
during 
pregnancy 
Total 
cases 
(a)* 
Sample 
rates* 
(b)** 
95% 
Conf. 
Interval* 
(c)*** 
Rate for 
all 
enrolled 
children 
(d) 
Range of 
rates for all 
enrolled 
children* 
(e) 
Cases in 
randomly 
selected 
group 
(f) **** 
Sample 
rate from 
random 
selection 
(g) ***** 
Widest 
range of 
rates from 
various 
methods  
FAS  5  3  8  8.2
  6.5–10.1
  4.0  4.0–8.2  2
  12.0
  4.0–12.0
 
PFAS  21  15  36  36.9  32.7–40.6  18.1  18.1–36.9  7  46.3  18.1–46.3 
ARBD
1  1  0  1  1.0  -  0.5  0.5–1.0  -  0.5  0.5–1.0 
ARND
1  1  0  1  1.0  -  0.5  0.5–1.0  -  0.5  0.5–1.0 
Total  28  18  46  47.1  33.4–62.6  23.1  23.1–47.1  9  59.4  23.1–62.6 
*  Rate  per  1,000  children  based  on  the  sample  screened,  denominator  =  976.  **  95%  confidence 
intervals were calculated via the two different, independent samples of different 1
st grade cohorts as 
discrete.  ***  Rate  per  1,000  children  enrolled  in  first  grade  classrooms  which  assumes  that 
oversampling of small children and teacher-referred children included a majority of ―at risk‖ cases. **** 
Rate per 1,000 children based on those selected at random for possible controls and after testing some 
children were found to have an FASD. Rate of children converting to an FASD diagnosis projected to 
the non-consented population then added to cases found in the consented population and divided by the 
total enrolled population. ***** Widest range of rates calculated from the various methods employed in 
Table 4. 
1ARBD and ARND cannot be diagnosed without direct confirmation of maternal alcohol use in 
the index pregnancy. 
 
The second method of estimation is found in column ―c‖ of Table 4, where calculations are based 
on  a  denominator  of  the  total  children  enrolled  in  the  first  grade  classrooms  (n  =  1,988).  This Int. J. Environ. Res. Public Health 2011, 8                 
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represents a conservative prevalence estimate, and this technique is warranted given the fact that over 
sampling of children was undertaken in this study by including all children in the ―at risk‖ categories 
of ≤10th centile on height, weight, and head circumference and those referred by teachers as suspected 
of having behavioral or learning problems. The rates utilizing this technique are: 4.0 per 1,000 for FAS, 
18.1 per 1,000 for PFAS, and 23.1 per 1,000 for all FASD cases found. In column ―d‖ then, a wider 
range of estimates is found, where the higher numbers are the average sample rates and the lower rate 
is that estimated from all enrolled children: 4.0 to 8.2 per 1,000 FAS, 18.1 to 36.9 per 1,000 PFAS, and 
23.1 to 47.1 per 1,000 for total FASD. 
Third, a single rate estimate can be produced by projecting the positive diagnosis rate of FASD 
found among the consented randomly-selected children to the number of children in the non-consented 
portion of the population. If the prevalence of various FASD diagnoses occur at the same rate in the 
non-consenting population as in those that were randomly-selected from the consented population, 
then  we  have  another  reasonable  and  accurate  way  of  estimating  the  prevalence  of  FASD  and 
individual  diagnoses  within.  Nine  consented  children,  selected  originally  as  random  controls, 
converted to a diagnosis within the spectrum of FASD: two converted to FAS and seven to PFAS (see 
column ―e‖ in Table 4). Therefore, 71 per 1,000 or 7.1% of the original 126 (9/126) consented children 
picked initially as candidates for normal controls converted to an FASD diagnosis. When projected to 
the  1,012  children  not  provided  consent,  72  additional  cases  are  estimated.  When  added  to  the 
diagnosed cases in the consented population the yield is an FASD rate of 59.4 per 1,000 (or 5.9%). 
Using the same projection method applied to FAS only, the single rate of FAS may be 12.0 per 1,000 
or 1.2% (see column ―f‖ in Table 4), and the single rate of PFAS is 46.3 per 1,000 or 4.3%. The widest 
range of estimated rates are summarized in column g. 
4. Discussion 
4.1. Prevalence Findings 
In this study we have used well-established, active case ascertainment, in-school study methods and 
techniques  employed  by  a  highly  experienced  team  of  classical  and  epidemiologic  researchers  to 
gather evidence on the prevalence of specific diagnoses within the continuum of FASD. Forty-six first 
grade children in the central study schools were found to have a diagnosis within the FASD continuum 
for their physical, developmental, and prenatal histories were found to be consistent with cases found 
elsewhere in the world. Because of the population-based sampling methods employed, we are able to 
utilize these empirical methods to estimate the prevalence of FASD within these communities. Using 
three calculation methods, the rates of FAS and total FASD were calculated. First, the sample rate of 
FAS was the highest at 8.2 per 1,000 and a 95% CI range of rates for FASD of 33.4 to 62.6 per 1,000. 
Second, the rate for all enrolled children produced by the over-sampling (of small children) method 
employed was lower at 4.0 per 1,000 for FAS and a range of 23.1 to 47.1 for FASD. Finally, the 
random sample of the consented children produced a high rate of FAS at 12.0 per 1,000 and a single, 
rate of FASD at 59.4 per 1,000, but a rate which is high within the sample 95% confidence intervals. 
Therefore combining the range of rates from the three estimates, the rate of FAS in this central Italian Int. J. Environ. Res. Public Health 2011, 8                 
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population is between 4.0 to 12.0 per 1,000 and the rate of FASD is between 23.1 and 62.6 per 1,000 
or 2.3% to 6.3%. 
4.2. Implications 
The high rates of FASD, particularly FAS and PFAS, presented here are provocative. They are 
substantively higher than the often quoted rates of 0.5 to 3.0 per 1.000 for FAS and 1% for FASD [18].
 
We note here that none of our experience with the methods used, or the presentation of clinical traits of 
children in Italy, was atypical of our experience in studies implemented in large samples in South 
Africa  [32,35,37],  with  referral  clinics  in  the  U.S.  [26-28,31],
  or  similar  in-school  pilot  studies 
underway in a Western U.S. city [18]. Recent advances in diagnostic methods and skills made in 
recent studies have clarified the criteria for diagnosing and recognizing FASD [41]. We believe that 
the rates of FAS and PFAS presented here are accurate, and indicate that the prevalence of FASD is 
higher in Italy than previously believed. Clinically, our team found the presentation of the FASD cases 
to be similar in their characteristics to those of other populations we have worked in and studied.  
Because the risk factors for FASD are more severe in study populations in South Africa, where 
most  in-school  studies  have  occurred,  and  the  occurrence  of  FAS  and  PFAS  is  substantially  
more  frequent  there  (46  to  89  per  1,000)  [32,34,36],
  direct  comparisons  of  these  FASD  rates  
and  characteristics  in  Italy  to  South  Africa  are  less  useful  than  would  be  a  comparison  to  other  
highly-developed populations. But there are few reported active case ascertainment studies in Europe 
and the U.S. In the one pilot study carried out in schools in the U.S., only FAS was assessed. The rate 
reported was 3.1 per 1,000 [21], certainly close to the FAS prevalence reported in this study from the 
total enrollment and higher than rates reported by other methods [18]. Interestingly only one of the 
seven children with FAS reported in that U.S. study [21] had been diagnosed previously. As far as we 
know, none of the FAS children diagnosed in this Italian study had been previously diagnosed. Our 
literature review yielded only 24 cases of FAS reported in the Italian literature prior to our first wave 
of  research  in  Italy  in  2004  [38].  Additionally,  an  intensive,  prospective,  clinic-based  study  by  
Sokol et al. [50] in Cleveland also reported 3.1 FAS cases per 1,000. But overall, much lower rates 
have been reported by surveillance and clinic-based studies because FASD is difficult to diagnose (and 
is often missed) in newborns and infants [18,51]. 
This study utilized population-based screening to examine the prevalence and characteristics of 
FASD in a general population of Italy where the majority of the subjects were middle class and there 
was not a large disparity found in maternal social class or maternal education between the two groups, 
cases and controls. While one can argue that not having measures of maternal I.Q. might bias the 
neurobehavioral findings, previous explorations of such bias have not found a major influence on the 
verbal or non-verbal I.Q. or behavior problems of the children in this study [39,40]. Valuable insights 
into the risk for FASD in a Western European population were gained from this study. As might be 
expected in a population where heavy episodic (binge) drinking is not common, there were 4.5 cases of 
PFAS for each case of FAS. Moderate daily drinking may produce fewer severely dysmorphic cases 
within FASD, but this study clearly demonstrates that children of more moderate daily drinkers do 
suffer from increased dysmorphia and disabilities compatible with FASD . Int. J. Environ. Res. Public Health 2011, 8                 
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4.3. Limitations 
Certainly there are limitations to this study. First, reporting of prenatal drinking is imperfect in this 
and in maternal populations with a relatively high degree of education [42]. The maternal interviewers 
for  this  study  stated  that  the  low  rate  of  drinking  reported  during  these  pregnancies  represented 
substantial underreporting in their opinions. Therefore some cases of ARND may well have been 
missed.  Nevertheless,  current  drinking  measures  and  retrospective,  pre-pregnancy  drinking  reports 
provide additional useful information and checks for validity. Also, revised IOM criteria allow the 
diagnosis of FAS and PFAS without direct maternal reports of drinking when the specific dysmorphic 
traits found in a particular child are those that have been clearly linked to FASD in other species and in 
other human populations [32-37,51-54]. And collateral reports have proven valuable. But our ability to 
diagnosis ARND and ARBD are severely hampered by lack of reporting. Second, the participation rate 
in this study was not as high as desired (49%). Limitations of time and money only allowed for one 
permission slip per child to be sent home in each wave of research. Researchers attempted to account 
for this problem by recruitment and active follow-up of referred children believed by teachers to have 
learning and behavioral problems, thus ensuring greater capture of probable cases. Furthermore, the 
range of rates reported here attempts to correct for incomplete recruitment by assuming that the rate of 
FASD in the non-consented children was at least as high as for participants and a projection of the 
population of FASD found by random case selection to the non-consented children. Third, some I.Q. 
and behavioral tests that were desired for comparing Italian children to English-speaking populations 
were not translated or standardized in Italy, and, therefore, could not be used. Also, some American 
behavioral measures, such as the PBCL, were apparently utilized differently by Italian parents, for 
problem scores reported were substantially lower for all Italian children than those normally reported 
by Americans. Fourth and finally, because this study began first with and was primarily based on 
screening  and  exams  for  dysmorphic  features  and  poor  physical  growth,  the  cases  of  ARND  are 
severely undercounted. Using a different methodology which would begin first with behavioral and 
neurocognitive  testing  would  likely  yield  substantially  more  cases  of  ARND.  Also,  using  totally 
random methods might produce more children with ARND and minimal dysmorphia. 
5. Conclusions 
The  rates  of  FAS  and  PFAS  among  the  children  in  this  region  of  Italy  are  high  compared  to 
previous estimates for the Western world. Since the currently accepted rates of FAS in the U.S. are  
0.5 to 3.0 per 1,000 [20,26], and total FASD is estimated at 1% [13], the rates of FAS and FASD in 
these  Italian  communities  are  significantly  higher  than  previously  estimated  for  a  developed  
country [18,22-24].
 No matter which of the rates produced here by various methods are used, the 
currently accepted rates for the U.S. and Europe seem to be unrealistically low.  
Insight has also been gained into the FASD implications for the Italian drinking style. Regular 
drinking during meals in a well-nourished and well-educated maternal population, (as opposed to a 
poorly nourished, low SES, binge drinking population), can produce a number of children with FASD. 
The drinking style of some women in this study obviously exceeds quantities and frequencies that are 
safe in this population. Children with an FASD present substantial challenges to any and all parents, Int. J. Environ. Res. Public Health 2011, 8                 
 
2347 
schools, clinicians, and societies; thus, there is a need to identify such children early so that their 
development  and  normal  adaptive  skills  can  be  maximized  and  FASD  prevention  initiated  for 
individual mothers, families, and larger groups of aggregates. This message may and should resonate 
with other Western European populations and also for the U.S. population, for we feel that this study 
has carefully examined a population with social and economic characteristics similar to thousands of 
others in the western world. 
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